| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000041510 |
| Receipt No. | R000047383 |
| Scientific Title | Clinical application of autogenous demineralized dentin matrix prepared immediately after extraction for alveolar bone regeneration |
| Date of disclosure of the study information | 2020/08/21 |
| Last modified on | 2020/08/21 (Ver. 1) |
| Basic information | ||
| Public title | Clinical application of autogenous demineralized dentin matrix prepared immediately after extraction for alveolar bone regeneration | |
| Acronym | Clinical application of ADDM after extraction for alveolar bone regeneration | |
| Scientific Title | Clinical application of autogenous demineralized dentin matrix prepared immediately after extraction for alveolar bone regeneration | |
| Scientific Title:Acronym | Clinical application of ADDM after extraction for alveolar bone regeneration | |
| Region |
|
|
| Condition | ||
| Condition | Lost of alveolar bone | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to estimate the efficacy of the DDM as biomaterial for bone regeneration. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | After implantation of the ADDM at 4, 8, 16, and/or 24 weeks, we evaluated the tissue with histology and radiology. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | autogenous demineralized dentin matrix | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The subjects were patients who required bone augmentation for dental implant treatment including 1) socket preservation, 2) maxillary sinus floor augmentation, and 3) alveolar ridge augmentation during dental implant placement simultaneous with tooth extraction. | |||
| Key exclusion criteria | a) Patients who had undergone radiation therapy in the oral and maxillofacial region,b) Patients who had undergone other bone grafting in the surgical area, and who had the history of maxillary sinus disease or symptoms were excluded.
c) Patients who had uncontrolled systemic disease were also excluded. |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagasaki University Graduate School of Biomedical Sciences | ||||||
| Division name | Department of Regenerative Oral Surgery, Unit of Translational Medicine | ||||||
| Zip code | 852-8588 | ||||||
| Address | 1-7-1 Sakamoto, Nagasaki-city, Nagasaki, Japan | ||||||
| TEL | 095-819-7704 | ||||||
| nanchan@nn.iij4u.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagasaki University Graduate School of Biomedical Sciences | ||||||
| Division name | Department of Regenerative Oral Surgery, Unit of Translational Medicine | ||||||
| Zip code | 852-8588 | ||||||
| Address | 1-7-1 Sakamoto, Nagasaki-city, Nagasaki, Japan | ||||||
| TEL | 095-819-7704 | ||||||
| Homepage URL | |||||||
| nanchan@nn.iij4u.or.jp | |||||||
| Sponsor | |
| Institute | Department of Regenerative Oral Surgery, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Regenerative Oral Surgery, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nagasaki University Hospital |
| Address | 1-7-1 Sakamoto, Nagasaki-city, Nagasaki, Japan |
| Tel | 095-819-7229 |
| gaibushikin@ml.nagasaki-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.ijoms.com/article/S0901-5027(17)31571-0/fulltext |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://www.ijoms.com/article/S0901-5027(17)31571-0/fulltext | ||||||
| Number of participants that the trial has enrolled | 40 | ||||||
| Results | The clinical application of APDDM prepared immediately after tooth extraction to bone augmentation, taking advantage of the relatively short preparation time due to partial demineralization. APDDM, as introduced in this study, is an efficient, safe, and reasonable bone substitute. Consequently, this material has the potential to become one of the options as a bone substitute in implant dentistry. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | As Protocol. |
||||||
| Participant flow | As Protocol. |
||||||
| Adverse events | Nothing Particular. |
||||||
| Outcome measures | As Protocol. |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047383 |